Skip to main content
Log in

Consecutive intra-umbilical vein injection of misoprostol and intravenous sulprostone in the management of retained placenta

  • Maternal-Fetal Medicine
  • Published:
Archives of Gynecology and Obstetrics Aims and scope Submit manuscript

Abstract

Introduction

Consecutive intra-umbilical vein injection of misoprostol and intravenous sulprostone in the management of retained placenta (RP).

Purpose

The general accepted treatment of RP is manual removal of the placenta (MRP), but medical intervention protocols were suggested. We evaluate a protocol of using intra-umbilical vein injection of misoprostol followed, if necessary, by intravenous sulprostone. A reduction in the need for MRP and less blood loss was expected.

Methods

Cohort A (1 January 2007 to 31 September 2008), managed by an expectative protocol including active management of the third stage of labor and if necessary MRP performed 60 min after birth of the baby, was compared with cohort B (1 April 2009 to 31 December 2010) managed by medical intervention protocol. This protocol consisted of intra-umbilical vein injection of misoprostol and if not successful, 250 μg of sulprostone was given intravenously in 30 min. All vaginal deliveries after 24 weeks of gestation, with RP after 20 min and blood loss <500 mL were included. An intention to treat analysis was performed, with the need for MRP as the primary outcome.

Results

Baseline characteristics were similar. In cohort A, 275 women met the inclusion criteria and 57 (20.7 %) women needed MRP. In cohort B, 219 women were included and 35 (16 %) women needed MRP. There was no significant difference in number of MRP, the amount of blood loss and other secondary outcomes.

Conclusions

We conclude that the use of intra-umbilical vein injection of misoprostol and intravenous sulprostone consecutively, does not reduce the number of MRPs as well as the total amount of blood loss in women with RP after 20 min. The study shows that changing obstetric management by extrapolating results from specific study groups to a general population may lead to other results.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

References

  1. Carroli G, Bergel E (2001) Umbilical vein injection for management of retained placenta. Cochrane Database Syst Rev 4:CD001337

    PubMed  Google Scholar 

  2. Van Beekhuizen HJ, de Groot AN, De Boo T, Burger D, Jansen N, Lotgering FK (2006) Sulprostone reduces the need for the manual removal of the placenta in patients with retained placenta: a randomized controlled trial. Am J Obstet Gynecol 194(2):446–450

    Article  PubMed  Google Scholar 

  3. Bais JM, Eskes M, Pel M, Bonsel GJ, Bleker OP (2004) Postpartum haemorrhage in nulliparous women: incidence and risk factors in low and high risk women. A Dutch population-based cohort study on standard (≥500 ml) and severe (≥1,000 ml) post-partum haemorrhage. Eur J Obstet Gynecol Reprod Biol 115(2):166–172

    PubMed  Google Scholar 

  4. Weeks Andrew D (2008) The retained placenta. Best Pract Res Clin Obstet Gynaecol 22(6):1103–1117

    Article  PubMed  Google Scholar 

  5. Rogers MS, Yeun PM, Wong S (2007) Avoiding manual removal of placenta: evaluation of intra-umbilical injection of uterotonics using Pipingas technique for management of adherent placenta. Acta Obstet Gynecol Scand 86(1):48–54

    Article  CAS  PubMed  Google Scholar 

  6. World Health Organization (2009) WHO guidelines for the management of postpartum haemorrhage and retained placenta. ISBN 978 92 4 159851 4

  7. Hagenaars M, Knape JT, Backus EM (2011) Pulmonary oedema after high infusion rate of sulprostone. URL: http://bja.oxfordjournals.org. Accessed on 25 Apr 2011

  8. Chen FG, Koh KF, Chong YS (1998) Cardiac arrest associated with sulprostone use during caesarean section. Anaesth Intensive Care 26(3):298–301

    CAS  PubMed  Google Scholar 

  9. Stefanovic V, Paavonen J, Loukovaara M, Halmesmäki E, Ahonen J, Tikkanen M (2013) Intravenous sulprostone infusion in the treatment of retained placenta. Acta Obstet Gynecol Scand 92(4):426–432

    Google Scholar 

  10. Nardin JM, Weeks A, Carroli G (2011) Umbilical vein injection for management of retained placenta. Cochrane Database Syst Rev Issue 5, CD001337. doi: 10.1002/14651858.CD001337

  11. Harara R, Hanafy S, Saad Alsayed Zidan M, Alberry M (2011) Intraumbilical injection of three different uterotonics in the management of retained placenta. J Obst Gynaecol Res 37(9):1203–1207

    Article  CAS  Google Scholar 

Download references

Conflict of interest

None of the authors have a conflict of interest.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Frouke Notten.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Notten, F., Meertens, L., Wissink, B. et al. Consecutive intra-umbilical vein injection of misoprostol and intravenous sulprostone in the management of retained placenta. Arch Gynecol Obstet 289, 35–40 (2014). https://doi.org/10.1007/s00404-013-2919-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00404-013-2919-4

Keywords

Navigation